Deoxyfluorination using Metal fluorides
Deoxyfluorination using Metal fluorides
批准号:
EP/Y026853/1
负责人:
Anirban Mondal
金额:
$25.55万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2024
资助国家:
英国
项目状态:
未结题
起止时间:
2024 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Organofluorine compounds that contain a carbon-fluorine bond are used in a variety of applications, including pharmaceutical drugs to treat diseases, high-performance advanced materials, and agrochemicals for food supply to a growing population. The finite nature of many resources including the limited environmental tolerance towards our chemical industry requires transitioning towards more sustainable and safe chemistry. The linear route of production, in which scarce resources are consumed and their value-added products are degraded to waste, is a route cause of global crises such as climate change, diminished biodiversity, as well as food, water, and energy shortages. Within this context, innovation to produce fluorochemicals applying protocols that meet today's performance metrics, such as high performance, safety, and sustainability, is vital. In this context, our goal is to synthesize critically needed organofluorine compounds from safe and inexpensive metal alkali fluoride such as potassium fluoride. Specifically, this proposal aims at inventing a new reaction to convert readily available alcohols into fluorochemicals using potassium fluoride instead of commonly used deoxyfluorination reagents [e.g. diethylaminosulfur trifluoride] that are derived from SF4, a hazardous chemical itself prepared from the dangerous chemical hydrogen fluoride. Our current approach is based on the Gouverneur group's previous studies on the new concept of "Hydrogen Bonding Phase Transfer Catalysis" for the activation of alkali metal fluorides with a hydrogen bond donor urea catalyst. Specifically, we propose a dual activation process for both the alcohol and potassium fluoride to convert readily available racemic alcohols into enantioenriched fluorinated motifs that are of importance for a pharmaceutical drug.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Capture and Release of Droplets Using Advanced Materials for High Technology Applications
-
批准号:52073127
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:Alidad Amirfazli
-
依托单位:
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
-
批准号:31070748
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:Christine Nardini
-
依托单位: